(Q47819047)

5 February 2018

review article

1 reference

title

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. (English)

1 reference

5 February 2018

author name string

Plotsky PM

series ordinal

1

1 reference

5 February 2018

Owens MJ

series ordinal

2

1 reference

5 February 2018

Nemeroff CB

series ordinal

3

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

Psychiatric Clinics of North America

published in

1 reference

5 February 2018

volume

21

1 reference

5 February 2018

page(s)

293-307

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

Behavior and corticosteroid response of Maudsley reactive and nonreactive rats in the open field and forced swimming test

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Elevated CSF CRF in suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Acute adverse reactions to prednisone in relation to dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Aetiology of anxiety and depressive disorders in an inner-city population. 2. Comorbidity and adversity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Aetiology of anxiety and depressive disorders in an inner-city population. 1. Early adversity.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Predicting the short-term outcome of first episodes and recurrences of clinical depression: a prospective study of life events, difficulties, and social support networks

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Adrenal cortical activity in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Pituitary-adrenal function in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Corticotrophin-releasing factor receptors: from molecular biology to drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Benzodiazepine anti-conflict effects in Maudsley reactive (MR/Har) and non-reactive (MNRA/Har) rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Anxiety-like and depression-like behavior in Maudsley reactive (MR) and non-reactive (NMRA) rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The role of the amygdala in fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

CRITICAL PERIODS, STIMULUS INPUT, AND EMOTIONAL REACTIVITY: A THEORY OF INFANTILE STIMULATION.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Glucocorticoids and the genesis of depressive illness. A psychobiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

A molecular and cellular theory of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Bipolar affective disorders linked to DNA markers on chromosome 11

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Plasma cortisol in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Phenomenology and family history of affective disorder in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Cushing's syndrome and depression--a prospective study of 26 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

A twin study of recent life events and difficulties

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Pituitary size in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Infantile experience and resistance to physiological stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Side effects of corticosteroid therapy. Psychiatric aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Psychiatric phenomenology in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Adrenal steroid receptors and actions in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Stress effects on morphology and function of the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Animal model of depression. I. Review of evidence: implications for research

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions*

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Adrenal gland enlargement in major depression. A computed tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Pathways to the secretion of adrenocorticotropin: a view from the portal*.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Plasma dexamethasone concentrations and the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Cortisol production in depressive illness. A clinical and biochemical clarification

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Hypercortisolism and its possible neural bases

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Nervous and mental disorders in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Neuropsychiatric aspects of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Glucocorticoid receptor binding in three different cell types in major depressive disorder: lack of evidence of receptor binding defect

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

The validity of animal models of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Increased adrenal weight in victims of violent suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

Psychiatric history and stress: predictors of severity of unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970006-X

7 January 2021

10.1016/S0193-953X(05)70006-X

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9670227

1 reference

5 February 2018